Tailin Biotechnology Co., Ltd.

Legal Opinion from Guohao Law Firm (Hangzhou) on Adjusting the Purchase Price of the 2026 Employee Stock Ownership Plan for Zhejiang Tailin Biotechnology Co., Ltd.

Announcement on Adjusting the Purchase Price of the 2026 Employee Stock Ownership Plan

Declaration and Commitment of Nominator for Independent Director (Ye Shuming)

Written Commitment from Independent Director Candidate Regarding Participation in the Most Recent Independent Director Training

Declaration and Commitment of Independent Director Candidate (Ye Shuming)

Announcement on the Resignation of Independent Directors upon Expiration of Their Terms and the Re-election of Independent Directors

Notice of the First Extraordinary Shareholders' Meeting in 2026

Announcement of Resolutions from the Thirteenth Meeting of the Fourth Board of Directors

Announcement on Obtaining Patent Certificate

Reminder announcement on the expiration of the first lock-up period of the 2025 employee stock ownership plan and the achievement of unlocking conditions

Announcement on the Completion of Account Opening for the 2026 Employee Stock Ownership Plan.

Reminder Announcement on the Disclosure of the 2026 First Quarter Report

Resolution Announcement of the 12th Meeting of the 4th Board of Directors

2026 First Quarter Report

Guohao Law Firm (Hangzhou) Legal Opinion on Zhejiang Tailin Biotechnology Co., Ltd. Issuing Convertible Bonds to Unspecified Objects

Financial Reports and Audit Reports for the Last Three Years and the Most Recent Financial Report

Changcheng Securities Co., Ltd. Listing Sponsorship Letter for Zhejiang Tailin Biotechnology Co., Ltd. Issuing Convertible Bonds to Unspecified Objects

Changcheng Securities Co., Ltd. Sponsorship Letter for Zhejiang Tailin Biotechnology Co., Ltd. Issuing Convertible Bonds to Unspecified Objects

Zhejiang Tailin Biotechnology Co., Ltd. Prospectus for Issuing Convertible Bonds to Unspecified Objects (Draft)

Announcement on the Application for Issuing Convertible Bonds to Unspecified Objects Accepted by Shenzhen Stock Exchange

Announcement on the completion of share repurchase reaching 1%

Announcement on the Implementation of the 2025 Annual Equity Distribution

Announcement on the First Share Buyback of the Company

Announcement of the annual general meeting resolution in 2025

Announcement on obtaining trademark registration certificates, patent certificates, and computer software copyright registration certificates

Legal opinion from Guohao Law Firm (Hangzhou) regarding the annual general meeting of Zhejiang Tailin Biotechnology Co., Ltd. in 2025

Legal Opinion from Guohao Law Firm (Hangzhou) on the 2026 Employee Stock Ownership Plan of Zhejiang Tailin Biotechnology Co., Ltd.

Announcement on the progress of the company's share repurchase

Announcement on Obtaining Patent Certificates and Computer Software Copyright Registration Certificates

Repurchase Report

Announcement on the Shareholding of Top Ten Shareholders and Top Ten Shareholders with Unlimited Sales Conditions Before Share Repurchase

Announcement on the Plan to Repurchase Company Shares

Assurance Report on the Use of Previous Raised Funds

Report on the Use of Previous Raised Funds

Shareholder Dividend Return Plan for the Next Three Years (2026-2028)

Announcement on Regulatory Measures or Penalties Taken by Securities Regulatory Authorities and Exchanges in the Past Five Years

Announcement on the Dilution of Immediate Returns, Measures to Compensate, and Related Commitments for Issuing Convertible Corporate Bonds to Unspecified Objects

Indicative Announcement on the Disclosure of the Pre-plan for Issuing Convertible Corporate Bonds to Unspecified Objects

Rules for Convertible Corporate Bondholders' Meetings

Feasibility Analysis Report on the Use of Funds Raised from Issuing Convertible Corporate Bonds to Unspecified Objects

Analysis Report on the Feasibility of Issuing Convertible Corporate Bonds to Unspecified Objects

Pre-plan for Issuing Convertible Corporate Bonds to Unspecified Objects

Verification Opinion of the Board of Directors' Remuneration and Assessment Committee on Matters Related to the Company's 2026 Employee Stock Ownership Plan

Board of Directors' Compliance Explanation on the Company's 2026 Employee Stock Ownership Plan (Draft)

Announcement of Resolutions of the Workers' Congress

Zhejiang Tailin Bioengineering Co., Ltd. 2026 Employee Stock Ownership Plan Management Measures

Summary of Zhejiang Tailin Bioengineering Co., Ltd. 2026 Employee Stock Ownership Plan (Draft)

Zhejiang Tailin Bioengineering Co., Ltd. 2026 Employee Stock Ownership Plan (Draft)

Verification Opinion of Great Wall Securities Co., Ltd. on Zhejiang Tailin Bioengineering Co., Ltd.'s Use of Part of Idle Raised Funds and Own Funds for Cash Management

Announcement on Using Part of Idle Raised Funds and Own Funds for Cash Management

2026-004 Indicative Announcement on the Disclosure of the 2025 Annual Report

Announcement on Re-appointing Tianjian Certified Public Accountants (Special General Partnership) as the Auditor for 2026

Independent Director's 2025 Annual Performance Report (Dong Ming)

Independent Director's 2025 Annual Performance Report (Ni Ya)

Independent Director's 2025 Annual Performance Report (Li Guowei)

Independent Director's 2025 Annual Performance Report (Yang Zhongzhi)

Announcement on Convening the 2025 Annual Online Performance Briefing

Internal Control Audit Report

2025 Annual Internal Control Self-Assessment Report

Remuneration Management System for Directors and Senior Management

Special Report on the Deposit and Use of Raised Funds in 2025

Announcement on the Estimated Daily Related Party Transactions for 2026

Notice of Convening the 2025 Annual General Meeting of Shareholders

2025 Annual Board of Directors' Work Report

2025 Annual Financial Settlement Report

Announcement on the Remuneration Plan for Directors and Senior Management for 2026

Announcement on the Company and its Wholly-Owned Subsidiaries Applying for Comprehensive Credit Lines from Banks

Announcement of Resolutions of the Eleventh Meeting of the Fourth Board of Directors

2025 Annual Profit Distribution Plan

Attestation Report on Annual Deposit and Use of Raised Funds

Great Wall Securities Co., Ltd. Verification Opinion on Zhejiang Tailin Biotechnology Co., Ltd.'s 2025 Annual Deposit and Use of Raised Funds

Assessment Report on the Accounting Firm's Performance of Duties in 2025

Audit Committee Report on the Supervision of the Accounting Firm's Performance of Duties in 2025

Special Audit Statement on Non-Operating Fund Occupation and Other Related Fund Transactions

2025 Annual Summary Table of Non-Operating Fund Occupation and Other Related Fund Transactions

Special Report of the Board of Directors on Independent Directors' Self-Inspection of Independence

2025 Annual Audit Report

2025 Annual Report

2025 Annual Report Summary

Announcement on Obtaining Patent Certificates